Clinical Trial Update: Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

Phase 4 multicenter placebo-controlled trial evaluating the effect of rasagiline on sleep-wake disturbances in Parkinson's disease; the study status is terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• RASAGILINE (rasagiline)

Snippet

Sponsor: University of Zurich | Conditions: Parkinson's Disease | Phase 4 | Status: TERMINATED